• 1
    Krotkiewski, M., Blohme, B., Lindholm, N., Björntorp, P. (1976) The effects of adrenal corticosteroids on regional adipocyte size in man. J Clin Endocrinol Metab. 42: 9197.
  • 2
    Malaisse, WJ, Malaisse-Lagae, F., Wright, PH (1970) Diabetogenesis. Adv Metab Disord. 1: 85 (suppl),.
  • 3
    Rebuffe-Scrive, M., Krotkiewski, M., Elfverson, J., Björntorp, P. (1988) Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J Clin Endocrinol Metab. 67: 11221128.
  • 4
    Livingstone, DE, Kenyon, CJ, Walker, BR (2000) Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats. J Endocrinol. 167: 533539.
  • 5
    Ljung, T., Andersson, B., Bengtsson, BA, Björntorp, P., Marin, P. (1996) Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obes Res. 4: 277282.
  • 6
    Migeon, CJ, Green, OC, Eckert, JP (1963) Study of adrenocortical function in obesity. Metabolism 12: 718739.
  • 7
    Strain, GW, Zumoff, B., Kream, J., Strain, JJ, Levin, J., Fukushima, D. (1982) Sex difference in the influence of obesity on the 24 hr mean plasma concentration of cortisol. Metabolism 31: 209212.
  • 8
    Bujalska, IJ, Kumar, S., Stewart, PM (1997) Does central obesity reflect “Cushing's disease of the omentum”? Lancet. 349: 12101213.
  • 9
    Seckl, JR, Walker, BR (2001) Minireview: 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific amplifier of glucocorticoid action. Endocrinology 142: 13711376.
  • 10
    Katz, JR, Mohamed-Ali, V., Wood, PJ, Yudkin, JS, Coppack, SW (1999) An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue. Clin Endocrinol (Oxf). 50: 6368.
  • 11
    Livingstone, DE, Jones, GC, Smith, K., et al (2000) Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141: 560563.
  • 12
    Liu, Y., Nakagawa, Y., Wang, Y., et al (2003) Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice. Diabetes 52: 14091416.
  • 13
    Masuzaki, H., Paterson, J., Shinyama, H., et al (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294: 21662170.
  • 14
    Morton, NM, Paterson, JM, Masuzaki, H., et al (2004) Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53: 931938.
  • 15
    Kotelevtsev, Y., Holmes, MC, Burchell, A., et al (1997) 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A. 94: 1492414929.
  • 16
    Rask, E., Olsson, T., Soderberg, S., et al (2001) Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab. 86: 14181421.
  • 17
    Rask, E., Walker, BR, Soderberg, S., et al (2002) Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab. 87: 33303336.
  • 18
    Engeli, S., Bohnke, J., Feldpausch, M., et al (2004) Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res. 12: 917.
  • 19
    Paulmyer-Lacroix, O., Boullu, S., Oliver, C., Alessi, MC, Grino, M. (2002) Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab. 87: 27012705.
  • 20
    Wake, DJ, Rask, E., Livingstone, DE, Soderberg, S., Olsson, T., Walker, BR (2003) Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab. 88: 39833988.
  • 21
    Westerbacka, J., Yki-Jarvinen, H., Vehkavaara, S., et al (2003) Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. J Clin Endocrinol Metab. 88: 49244931.
  • 22
    Kannisto, K., Pietilainen, KH, Ehrenborg, E., et al (2004) Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. J Clin Endocrinol Metab. 89: 44144421.
  • 23
    Lindsay, RS, Wake, DJ, Nair, S., et al (2003) Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab. 88: 27382744.
  • 24
    Nair, S., Lee, YH, Lindsay, RS, et al (2004) 11beta-Hydroxysteroid dehydrogenase type 1: genetic polymorphisms are associated with type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle. Diabetologia 47: 10881095.
  • 25
    World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. WHO/NCD/NCS/99 2 Geneva, Switzerland.
  • 26
    Tataranni, PA, Ravussin, E. (1995) Use of dual-energy X-ray absorptiometry in obese individuals. Am J Clin Nutr. 62: 730734.
  • 27
    Matthews, DR, Hosker, JP, Rudenski, AS, Naylor, BA, Treacher, DF, Turner, RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412419.
  • 28
    Agarwal, AK, Monder, C., Eckstein, B., White, PC (1989) Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. J Biol Chem. 264: 1893918943.
  • 29
    Tomlinson, JW, Sinha, B., Bujalska, I., Hewison, M., Stewart, PM (2002) Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. J Clin Endocrinol Metab. 87: 56305635.
  • 30
    Draper, N., Echwald, SM, Lavery, GG, et al (2002) Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. J Clin Endocrinol Metab. 87: 49844990.
  • 31
    Thieringer, R., Le Grand, CB, Carbin, L., et al (2001) 11 Beta-hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages. J Immunol. 167: 3035.
  • 32
    Gregoire, F., Genart, C., Hauser, N., Remacle, C. (1991) Glucocorticoids induce a drastic inhibition of proliferation and stimulate differentiation of adult rat fat cell precursors. Exp Cell Res. 196: 270278.
  • 33
    Ruan, H., Zarnowski, MJ, Cushman, SW, Lodish, HF (2003) Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes. J Biol Chem. 278: 4758547593.
  • 34
    Hirsch, J., Gallian, E. (1968) Methods for the determination of adipose cell size in man and animals. J Lipid Res. 9: 110119.
  • 35
    Weyer, C., Foley, JE, Bogardus, C., Tataranni, PA, Pratley, RE (2000) Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43: 14981506.
  • 36
    Reynolds, RM, Walker, BR, Syddall, HE, Whorwood, CB, Wood, PJ, Phillips, DI (2001) Elevated plasma cortisol in glucose-intolerant men: differences in responses to glucose and habituation to venepuncture. J Clin Endocrinol Metab. 86: 11491153.